BLUESTONE STRATEGIES, LLC

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Income

$16.6M

Filings

434

Unique Clients

Active Period

2010–2026

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2026	$450,000	15	5
2025	$810,000	27	7
2024	$1,160,000	27	7
2023	$1,322,500	35	10
2022	$1,410,000	29	7
2021	$1,280,000	34	8
2020	$1,210,000	30	8
2019	$1,140,000	25	7
2018	$1,150,000	28	7
2017	$1,130,000	28	7
2016	$1,190,000	30	8
2015	$1,065,000	27	7
2014	$925,000	24	6
2013	$815,000	25	6
2012	$750,000	23	6
2011	$711,000	23	5
2010	$70,000	4	2

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
AMERICA'S HEALTH INSURANCE PLANS (AHIP)	$3,560,000	67	2010–2026
KAISER FOUNDATION HEALTH PLANS	$3,550,000	67	2011–2026
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)	$2,930,000	56	2011–2024
SERCO INC	$2,760,000	55	2012–2025
TOMPKINS STRATEGIES LLC (ON BEHALF OF AFFORDABLE HEALTHCARE FOR AMERICANS)	$620,000	21	2016–2021
MERIDIAN HEALTH PLAN	$545,000	15	2015–2018
TOMPKINS STRATEGIES, LLC	$450,000	18	2013–2016
NORTHWEST POWER AND CONSERVATION COUNCIL	$400,000	14	2023–2026
VALYRIAN SMOKE LLC	$342,500	25	2021–2026
APEXHEALTH	$322,500	17	2019–2023
SILVERLINK COMMUNICATIONS LLC	$311,000	33	2011–2019
HEALING BREAKTHROUGH	$240,000	9	2023–2025
CARECORE NATIONAL LLC	$160,000	9	2010–2012
EVOLVE FOUNDATION INTERNATIONAL	$135,000	4	2023
BOCKORNY GROUP (ON BEHALF OF POST ACUTE MEDICAL)	$120,000	9	2020–2022
VALOR COALITION	$80,000	8	2025–2026
BUSINESS INTERRUPTION GROUP	$40,000	3	2020
MODERN ECONOMY PROJECT	$22,500	4	2023

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	368
SENATE	368
Centers For Medicare and Medicaid Services (CMS)	10
Congressional Budget Office (CBO)	5
Federal Trade Commission (FTC)	2
Health & Human Services, Dept of (HHS)	2
Medicare Payment Advisory Commission (MedPAC)	2

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	298
Medicare/Medicaid	Medicare/Medicaid	228
Pharmacy	Pharmacy	88
Insurance	Insurance	55
Small Business	Small Business	34
Aviation/Airlines/Airports	Aviation/Airlines/Airports	34
Defense	Defense	32
Telecommunications	Telecommunications	19
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	13
Government Issues	Government Issues	12
Budget/Appropriations	Budget/Appropriations	11
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	10
Energy/Nuclear	Energy/Nuclear	9
Accounting	Accounting	7
Immigration	Immigration	6
Veterans	Veterans	5
Torts	Torts	4
Natural Resources	Natural Resources	1
Economics/Economic Development	Economics/Economic Development	1
Marine/Maritime/Boating/Fisheries	Marine/Maritime/Boating/Fisheries	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5378118th Congress

Lower Costs, More Transparency Act

2024 · fourth_quarter · Client: KAISER FOUNDATION HEALTH PLANS

Open original LDA filing ↗

Cited source text and reported amounts

Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)

Client expense: — · Firm income: $60,000

Matched citations: HR 5378

H.R. 5378118th Congress

Lower Costs, More Transparency Act

2024 · fourth_quarter · Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP)

Open original LDA filing ↗

Cited source text and reported amounts

Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)

Client expense: — · Firm income: $60,000

Matched citations: HR 5378

S. 4753118th Congress

Energy Permitting Reform Act of 2024

2024 · fourth_quarter · Client: NORTHWEST POWER AND CONSERVATION COUNCIL

Open original LDA filing ↗

Cited source text and reported amounts

S.4753, the Energy Permitting Reform Act of 2024. Amendment to the permitting reform act lifting the prohibition on inflationary increase in the NWPCC budget

Client expense: — · Firm income: $30,000

Matched citations: S.4753

H.R. 5378118th Congress

Lower Costs, More Transparency Act

2024 · third_quarter · Client: KAISER FOUNDATION HEALTH PLANS

Open original LDA filing ↗

Cited source text and reported amounts

Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)

Client expense: — · Firm income: $60,000

Matched citations: HR 5378

Show 21 more cited filings

H.R. 5378118th Congress

Lower Costs, More Transparency Act

2024 · third_quarter · Client: AMERICA'S HEALTH INSURANCE PLANS (AHIP)

Open original LDA filing ↗

Cited source text and reported amounts

Federally-Funded Healthcare Programs including Medicaid and Medicare Advantage (MA) and the CY 2025 Medicare Advantage Advance Rate Notice. The Lower Costs, More Transparency Act (HR 5378)

Client expense: — · Firm income: $60,000

Matched citations: HR 5378

H.R. 5378118th Congress

Lower Costs, More Transparency Act

2024 · second_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $40,000

Matched citations: HR 5378

H.R. 5378118th Congress

Lower Costs, More Transparency Act

2024 · second_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $40,000

Matched citations: HR 5378

S. 127118th Congress

Pharmacy Benefit Manager Transparency Act of 2023

2024 · second_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $40,000

Matched citations: S. 127

S. 127118th Congress

Pharmacy Benefit Manager Transparency Act of 2023

2024 · second_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $40,000

Matched citations: S. 127

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · second_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $40,000

Matched citations: S. 1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · second_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $40,000

Matched citations: S. 1339

S. 1967118th Congress

PBM Act

2024 · second_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $40,000

Matched citations: S. 1967

S. 1967118th Congress

PBM Act

2024 · second_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $40,000

Matched citations: S. 1967

S. 1967118th Congress

PBM Act

2024 · second_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $40,000

Matched citations: S. 1967

H.R. 5378118th Congress

Lower Costs, More Transparency Act

2024 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $60,000

Matched citations: HR 5378

H.R. 5378118th Congress

Lower Costs, More Transparency Act

2024 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $60,000

Matched citations: HR 5378

S. 127118th Congress

Pharmacy Benefit Manager Transparency Act of 2023

2024 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $60,000

Matched citations: S. 127

S. 127118th Congress

Pharmacy Benefit Manager Transparency Act of 2023

2024 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $60,000

Matched citations: S. 127

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $60,000

Matched citations: S. 1339

S. 1339118th Congress

Pharmacy Benefit Manager Reform Act

2024 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $60,000

Matched citations: S. 1339

S. 1967118th Congress

PBM Act

2024 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $60,000

Matched citations: S. 1967

S. 1967118th Congress

PBM Act

2024 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug coverage, supply chain, and pharmacy benefits. S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $60,000

Matched citations: S. 1967

S. 1967118th Congress

PBM Act

2024 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $60,000

Matched citations: S. 1967

H.R. 5378118th Congress

Lower Costs, More Transparency Act

2023 · fourth_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to prescription drug coverage and pharmacy benefits. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $60,000

Matched citations: HR 5378

H.R. 5378118th Congress

Lower Costs, More Transparency Act

2023 · fourth_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

Open original LDA filing ↗

Cited source text and reported amounts

Pharmacy contracting issues related to drug pricing and pharmacy networks. HR 5378, The Lower Costs More Transparency Act S. 127, The PBM Transparency Act - Issues related to the FTC study of Pharmacy Benefit Managers. S. 1339, The Pharmacy Benefit Manager Reform Act - Issues related to the banning of spread pricing and rebate pass throughs S. 1967, The Patients Before Middlemen Act - Issues related to delinking and limiting PBMS ability to manage pharmacy benefits in Medicare.

Client expense: — · Firm income: $60,000

Matched citations: HR 5378

Source: Senate LDA

BLUESTONE STRATEGIES, LLC — Lobbying Disclosure | Poliscope